Merck loses Two Vioxx liability cases in one day
The verdict is th fourth multi-million dollar loss for Merck in Vioxx litigation.
The verdict is th fourth multi-million dollar loss for Merck in Vioxx litigation.
Recently, MSNBC’s Joe Scarborough revisited a shocking investigative news report by New York Times reporters, WALT BOGDANICH AND ERIC KOLI, published May 22, 2003.
Industry’s blockbuster sellers–the atypical antipsychotics performed WORSE than their cheaper, non-patented precursors.
"Even though clinical research is a noble and worthy activity, it’s very easy to lose your moral compass if your primary goal is the dollar amount of grant funding that you generate."
Steven Potkin, who, LAT reports, is a brother-in-law of Jane Pauley who wrapped up her career as TV news anchor to become a paid drug pusher.
Congressional leaders have lost patience with the cat and mouse game being played by officials of the National Institutes of Health.
Every federal oversight agency evaluating FDA’s safety performance has given the agency flunking grades. See:https://ahrp.org/cms/content/view/148/55/
The Times’ humorous profile of JAMA’s editor attempts to trivialize the threat to public health when journals fail to maintain the integrity of science-based medicine.
The harm done by journals’ failure to protect the integrity of science can hardly be overstated.
The American Society of Health System Pharmacists reports that the FDA "directed all makers of ADHD stimulants in May to strengthen the wording in the "Warnings" section of the labeling "with regard to serious cardiovascular events and psychiatric events."
The law firm of Baum Hedlund filed a lawsuit against GlaxoSmithKline, the maker of the antidepressant, Paxil, for causing severe heart defects in the newborn son, of a woman prescribed Paxil during her pregnancy.
Today’s New York Times editorial hits the mark–it’s right on target!